

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | barbed-end actin filament capping (GO:0051016) | 4.52645069 |
| 2 | skin morphogenesis (GO:0043589) | 4.46551349 |
| 3 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.32846012 |
| 4 | ribosome assembly (GO:0042255) | 4.30159380 |
| 5 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.19633595 |
| 6 | proteasome assembly (GO:0043248) | 4.17524735 |
| 7 | Golgi transport vesicle coating (GO:0048200) | 4.16062510 |
| 8 | COPI coating of Golgi vesicle (GO:0048205) | 4.16062510 |
| 9 | DNA strand elongation (GO:0022616) | 4.02246511 |
| 10 | DNA deamination (GO:0045006) | 3.99113491 |
| 11 | cell adhesion mediated by integrin (GO:0033627) | 3.98708155 |
| 12 | termination of RNA polymerase III transcription (GO:0006386) | 3.97143930 |
| 13 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.97143930 |
| 14 | telomere maintenance via recombination (GO:0000722) | 3.93557113 |
| 15 | DNA replication initiation (GO:0006270) | 3.93061618 |
| 16 | DNA replication checkpoint (GO:0000076) | 3.92780869 |
| 17 | protein localization to endosome (GO:0036010) | 3.89960225 |
| 18 | nucleobase biosynthetic process (GO:0046112) | 3.65570847 |
| 19 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.63194004 |
| 20 | purine nucleobase biosynthetic process (GO:0009113) | 3.59882005 |
| 21 | rRNA modification (GO:0000154) | 3.59440412 |
| 22 | mitotic recombination (GO:0006312) | 3.59300862 |
| 23 | CENP-A containing nucleosome assembly (GO:0034080) | 3.58882272 |
| 24 | mitotic metaphase plate congression (GO:0007080) | 3.57960213 |
| 25 | protein K6-linked ubiquitination (GO:0085020) | 3.57163993 |
| 26 | 7-methylguanosine mRNA capping (GO:0006370) | 3.52597763 |
| 27 | telomere maintenance via telomere lengthening (GO:0010833) | 3.50071092 |
| 28 | mitochondrial DNA replication (GO:0006264) | 3.49498619 |
| 29 | chromatin remodeling at centromere (GO:0031055) | 3.48878424 |
| 30 | virion attachment to host cell (GO:0019062) | 3.48033273 |
| 31 | adhesion of symbiont to host cell (GO:0044650) | 3.48033273 |
| 32 | deoxyribonucleotide biosynthetic process (GO:0009263) | 3.47831636 |
| 33 | 7-methylguanosine RNA capping (GO:0009452) | 3.47178189 |
| 34 | RNA capping (GO:0036260) | 3.47178189 |
| 35 | DNA-dependent DNA replication (GO:0006261) | 3.46436449 |
| 36 | glycosphingolipid catabolic process (GO:0046479) | 3.44702608 |
| 37 | hyaluronan catabolic process (GO:0030214) | 3.43682083 |
| 38 | ribosome biogenesis (GO:0042254) | 3.43296100 |
| 39 | hypotonic response (GO:0006971) | 3.42399839 |
| 40 | membrane raft organization (GO:0031579) | 3.42324559 |
| 41 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 3.41383328 |
| 42 | maturation of SSU-rRNA (GO:0030490) | 3.39476570 |
| 43 | keratan sulfate catabolic process (GO:0042340) | 3.39151573 |
| 44 | regulation of metalloenzyme activity (GO:0048552) | 3.38011698 |
| 45 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.37392050 |
| 46 | pinocytosis (GO:0006907) | 3.35590624 |
| 47 | transcription from RNA polymerase I promoter (GO:0006360) | 3.35419458 |
| 48 | apoptotic cell clearance (GO:0043277) | 3.34966223 |
| 49 | endodermal cell differentiation (GO:0035987) | 3.34906503 |
| 50 | protein retention in ER lumen (GO:0006621) | 3.34250435 |
| 51 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.33041637 |
| 52 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.31349977 |
| 53 | transcription-coupled nucleotide-excision repair (GO:0006283) | 3.29508423 |
| 54 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.29089666 |
| 55 | stress fiber assembly (GO:0043149) | 3.26960398 |
| 56 | regulation of early endosome to late endosome transport (GO:2000641) | 3.26688217 |
| 57 | termination of RNA polymerase I transcription (GO:0006363) | 3.26471234 |
| 58 | oligosaccharide catabolic process (GO:0009313) | 3.26352444 |
| 59 | formation of translation preinitiation complex (GO:0001731) | 3.25643917 |
| 60 | ribosomal small subunit biogenesis (GO:0042274) | 3.23677383 |
| 61 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.22811570 |
| 62 | ribosomal small subunit assembly (GO:0000028) | 3.22589603 |
| 63 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.22571051 |
| 64 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.21296529 |
| 65 | negative regulation of protein localization to plasma membrane (GO:1903077) | 3.20975298 |
| 66 | ribosomal large subunit biogenesis (GO:0042273) | 3.19986950 |
| 67 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.16091704 |
| 68 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.14690414 |
| 69 | glycolipid catabolic process (GO:0019377) | 3.13065593 |
| 70 | kinetochore assembly (GO:0051382) | 3.12700033 |
| 71 | deoxyribonucleoside diphosphate metabolic process (GO:0009186) | 3.11698854 |
| 72 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 3.11568874 |
| 73 | adhesion of symbiont to host (GO:0044406) | 3.09824485 |
| 74 | kinetochore organization (GO:0051383) | 3.09569763 |
| 75 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.09226080 |
| 76 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 3.08859781 |
| 77 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.07054271 |
| 78 | negative regulation of ligase activity (GO:0051352) | 3.07054271 |
| 79 | spliceosomal snRNP assembly (GO:0000387) | 3.06700174 |
| 80 | DNA replication-independent nucleosome organization (GO:0034724) | 3.06066203 |
| 81 | DNA replication-independent nucleosome assembly (GO:0006336) | 3.06066203 |
| 82 | metaphase plate congression (GO:0051310) | 3.05957597 |
| 83 | regulation of double-strand break repair via homologous recombination (GO:0010569) | 3.04929073 |
| 84 | protein maturation by protein folding (GO:0022417) | 3.04666319 |
| 85 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.04482813 |
| 86 | IMP biosynthetic process (GO:0006188) | 3.00669105 |
| 87 | maturation of 5.8S rRNA (GO:0000460) | 2.99689196 |
| 88 | transcription elongation from RNA polymerase I promoter (GO:0006362) | 2.99209420 |
| 89 | rRNA processing (GO:0006364) | 2.98671489 |
| 90 | transcription initiation from RNA polymerase I promoter (GO:0006361) | 2.97361055 |
| 91 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.95740368 |
| 92 | spliceosomal complex assembly (GO:0000245) | 2.94464812 |
| 93 | histone exchange (GO:0043486) | 2.93052835 |
| 94 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.91204586 |
| 95 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.91204586 |
| 96 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.91204586 |
| 97 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.90899718 |
| 98 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.89362551 |
| 99 | basement membrane organization (GO:0071711) | 2.89281190 |
| 100 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.88417657 |
| 101 | mesodermal cell differentiation (GO:0048333) | 2.87237599 |
| 102 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.86474613 |
| 103 | cell cycle G1/S phase transition (GO:0044843) | 2.86474613 |
| 104 | rRNA metabolic process (GO:0016072) | 2.86079257 |
| 105 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.84728635 |
| 106 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.84728635 |
| 107 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.84218726 |
| 108 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.84189404 |
| 109 | fibril organization (GO:0097435) | 2.84064137 |
| 110 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.83842827 |
| 111 | peptidyl-proline hydroxylation (GO:0019511) | 2.83722938 |
| 112 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.83667484 |
| 113 | spindle checkpoint (GO:0031577) | 2.83088908 |
| 114 | hemidesmosome assembly (GO:0031581) | 2.82024256 |
| 115 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 2.81430549 |
| 116 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 2.81430549 |
| 117 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 2.81430549 |
| 118 | negative regulation of sister chromatid segregation (GO:0033046) | 2.81430549 |
| 119 | COPII vesicle coating (GO:0048208) | 2.81389908 |
| 120 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.81092539 |
| 121 | extracellular fibril organization (GO:0043206) | 2.80062906 |
| 122 | blastocyst development (GO:0001824) | 2.79826344 |
| 123 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.79757460 |
| 124 | * positive regulation of receptor recycling (GO:0001921) | 2.79407106 |
| 125 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.79273979 |
| 126 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.79273979 |
| 127 | establishment of chromosome localization (GO:0051303) | 2.77537291 |
| 128 | substrate-dependent cell migration (GO:0006929) | 2.77053007 |
| 129 | chondrocyte proliferation (GO:0035988) | 2.76661603 |
| 130 | rRNA methylation (GO:0031167) | 2.76575420 |
| 131 | pseudouridine synthesis (GO:0001522) | 2.75592828 |
| 132 | wound healing, spreading of epidermal cells (GO:0035313) | 2.75494516 |
| 133 | negative regulation of chromosome segregation (GO:0051985) | 2.74826976 |
| 134 | mitotic spindle assembly checkpoint (GO:0007094) | 2.74722256 |
| 135 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.74467242 |
| 136 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.74467242 |
| 137 | positive regulation of ligase activity (GO:0051351) | 2.74447285 |
| 138 | transcription elongation from RNA polymerase II promoter (GO:0006368) | 2.73144195 |
| 139 | mitotic spindle checkpoint (GO:0071174) | 2.72871736 |
| 140 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.72792115 |
| 141 | negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100) | 2.72647027 |
| 142 | spindle assembly checkpoint (GO:0071173) | 2.72436871 |
| 143 | attachment of spindle microtubules to kinetochore (GO:0008608) | 2.71476315 |
| 144 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.70753989 |
| 145 | peptidyl-histidine modification (GO:0018202) | 2.69248257 |
| 146 | protein hydroxylation (GO:0018126) | 2.69026550 |
| 147 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 2.68859618 |
| 148 | regulation of extracellular matrix disassembly (GO:0010715) | 2.67999794 |
| 149 | response to thyroid hormone (GO:0097066) | 2.64721237 |
| 150 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.61660558 |
| 151 | ceramide catabolic process (GO:0046514) | 2.58807608 |
| 152 | vesicle coating (GO:0006901) | 2.57094574 |
| 153 | peptide catabolic process (GO:0043171) | 2.55374815 |
| 154 | epithelial cell-cell adhesion (GO:0090136) | 2.55365609 |
| 155 | regulation of mononuclear cell migration (GO:0071675) | 2.54264180 |
| 156 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.53312900 |
| 157 | positive regulation of extracellular matrix organization (GO:1903055) | 2.51271066 |
| 158 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.50868639 |
| 159 | low-density lipoprotein particle clearance (GO:0034383) | 2.50326712 |
| 160 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.49822589 |
| 161 | cell-substrate junction assembly (GO:0007044) | 2.48695033 |
| 162 | decidualization (GO:0046697) | 2.48575800 |
| 163 | collagen fibril organization (GO:0030199) | 2.48059771 |
| 164 | negative regulation of establishment of protein localization to plasma membrane (GO:0090005) | 2.47198050 |
| 165 | cellular response to vitamin (GO:0071295) | 2.44008865 |
| 166 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.43831376 |
| 167 | blood vessel maturation (GO:0001955) | 2.41703688 |
| 168 | cellular copper ion homeostasis (GO:0006878) | 2.41346805 |
| 169 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.40795994 |
| 170 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.40745477 |
| 171 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.38540859 |
| 172 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.38089751 |
| 173 | sphingolipid catabolic process (GO:0030149) | 2.38063201 |
| 174 | membrane lipid catabolic process (GO:0046466) | 2.37343505 |
| 175 | collagen metabolic process (GO:0032963) | 2.31084708 |
| 176 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.30869899 |
| 177 | negative regulation of complement activation (GO:0045916) | 2.29416885 |
| 178 | extracellular matrix disassembly (GO:0022617) | 2.28902323 |
| 179 | endothelium development (GO:0003158) | 2.28566887 |
| 180 | desmosome organization (GO:0002934) | 2.28559053 |
| 181 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.26173165 |
| 182 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.24929752 |
| 183 | type B pancreatic cell proliferation (GO:0044342) | 2.24521191 |
| 184 | platelet degranulation (GO:0002576) | 2.22520647 |
| 185 | membrane protein ectodomain proteolysis (GO:0006509) | 2.21946240 |
| 186 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.21862076 |
| 187 | cortical actin cytoskeleton organization (GO:0030866) | 2.21183429 |
| 188 | regulation of protein localization to plasma membrane (GO:1903076) | 2.21113515 |
| 189 | positive regulation of actin filament depolymerization (GO:0030836) | 2.20467977 |
| 190 | regulation of collagen metabolic process (GO:0010712) | 2.20456375 |
| 191 | embryo implantation (GO:0007566) | 2.20168500 |
| 192 | collagen catabolic process (GO:0030574) | 2.19656039 |
| 193 | extracellular matrix assembly (GO:0085029) | 2.19094170 |
| 194 | cellular response to arsenic-containing substance (GO:0071243) | 2.18981721 |
| 195 | multicellular organismal macromolecule metabolic process (GO:0044259) | 2.17801250 |
| 196 | cyclooxygenase pathway (GO:0019371) | 2.17448133 |
| 197 | response to laminar fluid shear stress (GO:0034616) | 2.16418322 |
| 198 | response to hyperoxia (GO:0055093) | 2.16108831 |
| 199 | response to increased oxygen levels (GO:0036296) | 2.16108831 |
| 200 | iron ion import (GO:0097286) | 2.15858327 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.47286354 |
| 2 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.18192462 |
| 3 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.01131813 |
| 4 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.99683576 |
| 5 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.90141562 |
| 6 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.73105885 |
| 7 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.56024525 |
| 8 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.46199968 |
| 9 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.31710966 |
| 10 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.19586085 |
| 11 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.18622909 |
| 12 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.10849505 |
| 13 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.93645530 |
| 14 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.92535886 |
| 15 | * CLOCK_20551151_ChIP-Seq_293T_Human | 2.92048925 |
| 16 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.89929896 |
| 17 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.80692745 |
| 18 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.80692014 |
| 19 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.80664423 |
| 20 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.80516355 |
| 21 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.78815954 |
| 22 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.76418034 |
| 23 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.76030245 |
| 24 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.70249625 |
| 25 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.69922169 |
| 26 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.66395377 |
| 27 | * CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.63450675 |
| 28 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.56678077 |
| 29 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.55023032 |
| 30 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 2.53029898 |
| 31 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.52311881 |
| 32 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.49254121 |
| 33 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.46242785 |
| 34 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.41759145 |
| 35 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 2.39927766 |
| 36 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.39613075 |
| 37 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.27135263 |
| 38 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.27018660 |
| 39 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.26452781 |
| 40 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.23917140 |
| 41 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.23385969 |
| 42 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.22684926 |
| 43 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.21403319 |
| 44 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.19424150 |
| 45 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.19022635 |
| 46 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 2.18780775 |
| 47 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 2.17601718 |
| 48 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.16457907 |
| 49 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.09990659 |
| 50 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.03026078 |
| 51 | * ELK1_19687146_ChIP-ChIP_HELA_Human | 2.02752873 |
| 52 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 2.02364567 |
| 53 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 2.02364567 |
| 54 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.99014991 |
| 55 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.98086052 |
| 56 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.97235220 |
| 57 | CJUN_26792858_Chip-Seq_BT549_Human | 1.95884742 |
| 58 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 1.94740912 |
| 59 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.94612654 |
| 60 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.90156564 |
| 61 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.89897021 |
| 62 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.88704481 |
| 63 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.86372950 |
| 64 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.85964229 |
| 65 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.84639135 |
| 66 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.84059134 |
| 67 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.83928601 |
| 68 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.82930212 |
| 69 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.79614918 |
| 70 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.77052621 |
| 71 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.76639533 |
| 72 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.74983229 |
| 73 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.74229662 |
| 74 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.71991009 |
| 75 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.71610230 |
| 76 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.70654846 |
| 77 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.67807918 |
| 78 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.66949559 |
| 79 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.65518264 |
| 80 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.65089858 |
| 81 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.62406139 |
| 82 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.62006320 |
| 83 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.61323173 |
| 84 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.60795091 |
| 85 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.60795091 |
| 86 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.60430759 |
| 87 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.59228611 |
| 88 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.58553111 |
| 89 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.57712458 |
| 90 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.56740308 |
| 91 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.55977783 |
| 92 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.54367725 |
| 93 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.53067944 |
| 94 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.51468494 |
| 95 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.49848720 |
| 96 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.47723657 |
| 97 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.44528137 |
| 98 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.43815973 |
| 99 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.42528689 |
| 100 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.42151292 |
| 101 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.40449830 |
| 102 | ATF3_27146783_Chip-Seq_COLON_Human | 1.39916652 |
| 103 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.38831487 |
| 104 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.38830830 |
| 105 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.38830830 |
| 106 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.38830830 |
| 107 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.38588189 |
| 108 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.37034762 |
| 109 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35806243 |
| 110 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.34380783 |
| 111 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.33987551 |
| 112 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.32017857 |
| 113 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31649088 |
| 114 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.30865390 |
| 115 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.30820301 |
| 116 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.30448221 |
| 117 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.30448221 |
| 118 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.29605264 |
| 119 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.29434854 |
| 120 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.27682609 |
| 121 | * PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.26882490 |
| 122 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.26253049 |
| 123 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.26058602 |
| 124 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.25723585 |
| 125 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.25687824 |
| 126 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.25674331 |
| 127 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.25585731 |
| 128 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.24560609 |
| 129 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24215882 |
| 130 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.23721722 |
| 131 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.23113523 |
| 132 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.22483823 |
| 133 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.21910214 |
| 134 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.20697015 |
| 135 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.18952788 |
| 136 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.16617840 |
| 137 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.16181853 |
| 138 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.15260691 |
| 139 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.15190754 |
| 140 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.14403078 |
| 141 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.13244151 |
| 142 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.13089856 |
| 143 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.12462595 |
| 144 | * KDM5A_27292631_Chip-Seq_BREAST_Human | 1.12236898 |
| 145 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.11199384 |
| 146 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.08389567 |
| 147 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.06936047 |
| 148 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 1.06578942 |
| 149 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.06107755 |
| 150 | SPI1_23127762_ChIP-Seq_K562_Human | 1.05120525 |
| 151 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.02931967 |
| 152 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.02787338 |
| 153 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.02016084 |
| 154 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.01330151 |
| 155 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.00114270 |
| 156 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.98458070 |
| 157 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.98266901 |
| 158 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.98208317 |
| 159 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.96857066 |
| 160 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.96198486 |
| 161 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.96046890 |
| 162 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.95626839 |
| 163 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.95017545 |
| 164 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.94886818 |
| 165 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.94560158 |
| 166 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.94354173 |
| 167 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.92264435 |
| 168 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.92074487 |
| 169 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.91383036 |
| 170 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.90926144 |
| 171 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.90340027 |
| 172 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.89925430 |
| 173 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.89847268 |
| 174 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.89276943 |
| 175 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.89153195 |
| 176 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.89136229 |
| 177 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.87960096 |
| 178 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.85848096 |
| 179 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.85582473 |
| 180 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.85385084 |
| 181 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.85267794 |
| 182 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.84835630 |
| 183 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.83096213 |
| 184 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.82951196 |
| 185 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.82463122 |
| 186 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.79498612 |
| 187 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.79462649 |
| 188 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.79094003 |
| 189 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.78494579 |
| 190 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.77286532 |
| 191 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.76839264 |
| 192 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.75983232 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 4.44552904 |
| 2 | MP0003111_abnormal_nucleus_morphology | 3.40717064 |
| 3 | MP0005058_abnormal_lysosome_morphology | 3.39709221 |
| 4 | MP0010094_abnormal_chromosome_stability | 3.30791047 |
| 5 | MP0004957_abnormal_blastocyst_morpholog | 3.29593076 |
| 6 | MP0003705_abnormal_hypodermis_morpholog | 3.16798755 |
| 7 | MP0008057_abnormal_DNA_replication | 3.16096876 |
| 8 | MP0003077_abnormal_cell_cycle | 3.06955253 |
| 9 | MP0008058_abnormal_DNA_repair | 3.06727221 |
| 10 | MP0010368_abnormal_lymphatic_system | 2.95847112 |
| 11 | MP0003191_abnormal_cellular_cholesterol | 2.88447157 |
| 12 | MP0003566_abnormal_cell_adhesion | 2.82502821 |
| 13 | MP0008007_abnormal_cellular_replicative | 2.67162803 |
| 14 | MP0005275_abnormal_skin_tensile | 2.64854625 |
| 15 | MP0008877_abnormal_DNA_methylation | 2.58159234 |
| 16 | MP0008932_abnormal_embryonic_tissue | 2.57714462 |
| 17 | MP0002877_abnormal_melanocyte_morpholog | 2.55431980 |
| 18 | MP0003279_aneurysm | 2.48687077 |
| 19 | MP0001958_emphysema | 2.38052329 |
| 20 | MP0010234_abnormal_vibrissa_follicle | 2.33279687 |
| 21 | MP0003786_premature_aging | 2.28071611 |
| 22 | MP0005257_abnormal_intraocular_pressure | 2.19375603 |
| 23 | MP0009840_abnormal_foam_cell | 2.11034027 |
| 24 | MP0003718_maternal_effect | 2.00573384 |
| 25 | MP0003123_paternal_imprinting | 1.85582730 |
| 26 | MP0003300_gastrointestinal_ulcer | 1.84639999 |
| 27 | MP0003941_abnormal_skin_development | 1.80902646 |
| 28 | MP0003186_abnormal_redox_activity | 1.78205501 |
| 29 | MP0003091_abnormal_cell_migration | 1.74749270 |
| 30 | MP0005623_abnormal_meninges_morphology | 1.74300365 |
| 31 | MP0006082_CNS_inflammation | 1.72676457 |
| 32 | MP0001730_embryonic_growth_arrest | 1.65183788 |
| 33 | MP0003075_altered_response_to | 1.63106608 |
| 34 | MP0003950_abnormal_plasma_membrane | 1.62590768 |
| 35 | MP0002060_abnormal_skin_morphology | 1.59803660 |
| 36 | MP0000767_abnormal_smooth_muscle | 1.53555942 |
| 37 | MP0005164_abnormal_response_to | 1.53386072 |
| 38 | MP0005165_increased_susceptibility_to | 1.51191751 |
| 39 | MP0003315_abnormal_perineum_morphology | 1.51037840 |
| 40 | MP0002896_abnormal_bone_mineralization | 1.45084947 |
| 41 | MP0000350_abnormal_cell_proliferation | 1.42769275 |
| 42 | MP0010030_abnormal_orbit_morphology | 1.42255943 |
| 43 | MP0009780_abnormal_chondrocyte_physiolo | 1.42170999 |
| 44 | MP0001879_abnormal_lymphatic_vessel | 1.41937620 |
| 45 | MP0003453_abnormal_keratinocyte_physiol | 1.40251179 |
| 46 | MP0003724_increased_susceptibility_to | 1.39731123 |
| 47 | MP0000566_synostosis | 1.38825094 |
| 48 | MP0006054_spinal_hemorrhage | 1.37500801 |
| 49 | MP0003172_abnormal_lysosome_physiology | 1.37384919 |
| 50 | MP0002210_abnormal_sex_determination | 1.35596480 |
| 51 | MP0002295_abnormal_pulmonary_circulatio | 1.35296612 |
| 52 | MP0001533_abnormal_skeleton_physiology | 1.26117536 |
| 53 | MP0009333_abnormal_splenocyte_physiolog | 1.25399099 |
| 54 | MP0002396_abnormal_hematopoietic_system | 1.25388929 |
| 55 | MP0008438_abnormal_cutaneous_collagen | 1.25036743 |
| 56 | MP0002998_abnormal_bone_remodeling | 1.23207978 |
| 57 | MP0010352_gastrointestinal_tract_polyps | 1.22717121 |
| 58 | MP0003303_peritoneal_inflammation | 1.22355953 |
| 59 | MP0001293_anophthalmia | 1.21793402 |
| 60 | MP0003567_abnormal_fetal_cardiomyocyte | 1.21593921 |
| 61 | MP0002160_abnormal_reproductive_system | 1.20055707 |
| 62 | MP0008004_abnormal_stomach_pH | 1.19989102 |
| 63 | MP0001672_abnormal_embryogenesis/_devel | 1.19455971 |
| 64 | MP0005380_embryogenesis_phenotype | 1.19455971 |
| 65 | MP0003937_abnormal_limbs/digits/tail_de | 1.17824536 |
| 66 | MP0001145_abnormal_male_reproductive | 1.17356612 |
| 67 | MP0001697_abnormal_embryo_size | 1.16918822 |
| 68 | MP0000313_abnormal_cell_death | 1.15385332 |
| 69 | MP0005451_abnormal_body_composition | 1.15011389 |
| 70 | MP0005171_absent_coat_pigmentation | 1.11839795 |
| 71 | MP0002277_abnormal_respiratory_mucosa | 1.09562890 |
| 72 | MP0002085_abnormal_embryonic_tissue | 1.09149639 |
| 73 | MP0008260_abnormal_autophagy | 1.08945829 |
| 74 | MP0004233_abnormal_muscle_weight | 1.08826982 |
| 75 | MP0002796_impaired_skin_barrier | 1.08069491 |
| 76 | MP0004510_myositis | 1.06922530 |
| 77 | MP0003984_embryonic_growth_retardation | 1.06894038 |
| 78 | MP0003890_abnormal_embryonic-extraembry | 1.06512756 |
| 79 | MP0005166_decreased_susceptibility_to | 1.05126875 |
| 80 | MP0005595_abnormal_vascular_smooth | 1.04431824 |
| 81 | MP0001915_intracranial_hemorrhage | 1.03973153 |
| 82 | MP0000490_abnormal_crypts_of | 1.03802878 |
| 83 | MP0001853_heart_inflammation | 1.03321208 |
| 84 | MP0000383_abnormal_hair_follicle | 1.02760140 |
| 85 | MP0002080_prenatal_lethality | 1.02685330 |
| 86 | MP0010307_abnormal_tumor_latency | 1.02195316 |
| 87 | MP0002088_abnormal_embryonic_growth/wei | 1.02019814 |
| 88 | MP0000604_amyloidosis | 1.01995872 |
| 89 | MP0003436_decreased_susceptibility_to | 1.01333900 |
| 90 | MP0009384_cardiac_valve_regurgitation | 1.01292117 |
| 91 | MP0000613_abnormal_salivary_gland | 0.99767876 |
| 92 | MP0000516_abnormal_urinary_system | 0.99727371 |
| 93 | MP0005367_renal/urinary_system_phenotyp | 0.99727371 |
| 94 | MP0005389_reproductive_system_phenotype | 0.99547442 |
| 95 | MP0001542_abnormal_bone_strength | 0.99507944 |
| 96 | MP0004133_heterotaxia | 0.99342622 |
| 97 | MP0003806_abnormal_nucleotide_metabolis | 0.99279051 |
| 98 | MP0002938_white_spotting | 0.98491699 |
| 99 | MP0008995_early_reproductive_senescence | 0.98412787 |
| 100 | MP0000653_abnormal_sex_gland | 0.98282165 |
| 101 | MP0006292_abnormal_olfactory_placode | 0.96513676 |
| 102 | MP0001929_abnormal_gametogenesis | 0.94472129 |
| 103 | MP0005390_skeleton_phenotype | 0.92988072 |
| 104 | MP0002111_abnormal_tail_morphology | 0.92983526 |
| 105 | * MP0005464_abnormal_platelet_physiology | 0.92329755 |
| 106 | MP0000751_myopathy | 0.92247768 |
| 107 | MP0004883_abnormal_blood_vessel | 0.91752865 |
| 108 | MP0002098_abnormal_vibrissa_morphology | 0.91421295 |
| 109 | MP0005408_hypopigmentation | 0.90862552 |
| 110 | MP0002019_abnormal_tumor_incidence | 0.90145775 |
| 111 | MP0001849_ear_inflammation | 0.89988027 |
| 112 | MP0000013_abnormal_adipose_tissue | 0.89814967 |
| 113 | MP0002971_abnormal_brown_adipose | 0.89240675 |
| 114 | MP0001661_extended_life_span | 0.88403066 |
| 115 | MP0006138_congestive_heart_failure | 0.87683266 |
| 116 | MP0005360_urolithiasis | 0.87377772 |
| 117 | MP0004272_abnormal_basement_membrane | 0.85774133 |
| 118 | MP0000249_abnormal_blood_vessel | 0.84961302 |
| 119 | MP0009053_abnormal_anal_canal | 0.84039235 |
| 120 | MP0000747_muscle_weakness | 0.82643663 |
| 121 | MP0005375_adipose_tissue_phenotype | 0.82125159 |
| 122 | MP0004197_abnormal_fetal_growth/weight/ | 0.82046736 |
| 123 | MP0000749_muscle_degeneration | 0.81902459 |
| 124 | MP0002332_abnormal_exercise_endurance | 0.81538503 |
| 125 | MP0000647_abnormal_sebaceous_gland | 0.81273549 |
| 126 | MP0005666_abnormal_adipose_tissue | 0.81120208 |
| 127 | MP0003448_altered_tumor_morphology | 0.81055569 |
| 128 | MP0002419_abnormal_innate_immunity | 0.80086395 |
| 129 | MP0003795_abnormal_bone_structure | 0.79436764 |
| 130 | MP0002132_abnormal_respiratory_system | 0.78899563 |
| 131 | MP0005409_darkened_coat_color | 0.78735051 |
| 132 | MP0002139_abnormal_hepatobiliary_system | 0.78688069 |
| 133 | MP0002084_abnormal_developmental_patter | 0.78676370 |
| 134 | MP0003121_genomic_imprinting | 0.78371106 |
| 135 | MP0004808_abnormal_hematopoietic_stem | 0.77916790 |
| 136 | MP0002086_abnormal_extraembryonic_tissu | 0.76089298 |
| 137 | MP0001286_abnormal_eye_development | 0.75896497 |
| 138 | MP0001119_abnormal_female_reproductive | 0.75695060 |
| 139 | MP0005384_cellular_phenotype | 0.74831003 |
| 140 | MP0001614_abnormal_blood_vessel | 0.74709176 |
| 141 | MP0004185_abnormal_adipocyte_glucose | 0.74018588 |
| 142 | MP0005508_abnormal_skeleton_morphology | 0.73206848 |
| 143 | MP0005330_cardiomyopathy | 0.71949812 |
| 144 | MP0003329_amyloid_beta_deposits | 0.71673847 |
| 145 | MP0000733_abnormal_muscle_development | 0.70920310 |
| 146 | MP0005621_abnormal_cell_physiology | 0.70882843 |
| 147 | MP0003136_yellow_coat_color | 0.70880153 |
| 148 | MP0001216_abnormal_epidermal_layer | 0.70811687 |
| 149 | MP0005501_abnormal_skin_physiology | 0.70460390 |
| 150 | MP0000432_abnormal_head_morphology | 0.70392489 |
| 151 | MP0005670_abnormal_white_adipose | 0.70194791 |
| 152 | MP0005503_abnormal_tendon_morphology | 0.69866796 |
| 153 | MP0004947_skin_inflammation | 0.69825375 |
| 154 | MP0000858_altered_metastatic_potential | 0.69507458 |
| 155 | MP0004858_abnormal_nervous_system | 0.68949175 |
| 156 | MP0005395_other_phenotype | 0.68622628 |
| 157 | MP0001851_eye_inflammation | 0.68504719 |
| 158 | MP0002128_abnormal_blood_circulation | 0.68091701 |
| 159 | MP0004147_increased_porphyrin_level | 0.67754481 |
| 160 | MP0003828_pulmonary_edema | 0.67638597 |
| 161 | MP0000003_abnormal_adipose_tissue | 0.67445776 |
| 162 | MP0000465_gastrointestinal_hemorrhage | 0.67310241 |
| 163 | MP0005023_abnormal_wound_healing | 0.67141886 |
| 164 | MP0005197_abnormal_uvea_morphology | 0.66676487 |
| 165 | MP0003936_abnormal_reproductive_system | 0.66384961 |
| 166 | MP0000750_abnormal_muscle_regeneration | 0.65896105 |
| 167 | MP0002148_abnormal_hypersensitivity_rea | 0.65598411 |
| 168 | MP0002972_abnormal_cardiac_muscle | 0.64723710 |
| 169 | MP0000762_abnormal_tongue_morphology | 0.63985803 |
| 170 | MP0000428_abnormal_craniofacial_morphol | 0.63026089 |
| 171 | MP0003119_abnormal_digestive_system | 0.62308750 |
| 172 | MP0000358_abnormal_cell_content/ | 0.60615165 |
| 173 | MP0000537_abnormal_urethra_morphology | 0.60402260 |
| 174 | MP0000343_altered_response_to | 0.59409442 |
| 175 | MP0001727_abnormal_embryo_implantation | 0.59224343 |
| 176 | MP0001243_abnormal_dermal_layer | 0.59027555 |
| 177 | MP0010678_abnormal_skin_adnexa | 0.57592438 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Premature rupture of membranes (HP:0001788) | 5.11003575 |
| 2 | Birth length less than 3rd percentile (HP:0003561) | 4.98711030 |
| 3 | Protrusio acetabuli (HP:0003179) | 4.95772032 |
| 4 | Breast hypoplasia (HP:0003187) | 4.57534159 |
| 5 | Abnormality of glycolipid metabolism (HP:0010969) | 4.28086716 |
| 6 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.28086716 |
| 7 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.28086716 |
| 8 | Vertebral compression fractures (HP:0002953) | 3.92993935 |
| 9 | Carpal bone hypoplasia (HP:0001498) | 3.74130546 |
| 10 | Cerebral hypomyelination (HP:0006808) | 3.69757822 |
| 11 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.51071325 |
| 12 | Chromsome breakage (HP:0040012) | 3.46430252 |
| 13 | Vascular tortuosity (HP:0004948) | 3.45372932 |
| 14 | Rough bone trabeculation (HP:0100670) | 3.37657916 |
| 15 | Dysostosis multiplex (HP:0000943) | 3.29353142 |
| 16 | Aortic aneurysm (HP:0004942) | 3.22744711 |
| 17 | Cervical subluxation (HP:0003308) | 3.21318836 |
| 18 | Reticulocytopenia (HP:0001896) | 3.14833139 |
| 19 | Arterial tortuosity (HP:0005116) | 3.14196190 |
| 20 | Duplicated collecting system (HP:0000081) | 3.11672410 |
| 21 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 3.11273914 |
| 22 | Aortic dissection (HP:0002647) | 3.10971475 |
| 23 | Progressive external ophthalmoplegia (HP:0000590) | 3.05589042 |
| 24 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 3.05487585 |
| 25 | Osteolytic defects of the hand bones (HP:0009699) | 3.05487585 |
| 26 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.03146912 |
| 27 | Mucopolysacchariduria (HP:0008155) | 3.03146912 |
| 28 | Vacuolated lymphocytes (HP:0001922) | 3.00745753 |
| 29 | Nuclear cataract (HP:0100018) | 2.93367206 |
| 30 | Absent radius (HP:0003974) | 2.92397646 |
| 31 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.92074494 |
| 32 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.92074494 |
| 33 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.92074494 |
| 34 | Systemic lupus erythematosus (HP:0002725) | 2.88223525 |
| 35 | Abnormality of the renal collecting system (HP:0004742) | 2.82344924 |
| 36 | Patellar aplasia (HP:0006443) | 2.79451396 |
| 37 | Abnormal trabecular bone morphology (HP:0100671) | 2.77234537 |
| 38 | Meckel diverticulum (HP:0002245) | 2.75257654 |
| 39 | Spinal rigidity (HP:0003306) | 2.70844781 |
| 40 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.69429939 |
| 41 | Abnormality of the anterior horn cell (HP:0006802) | 2.68755197 |
| 42 | Degeneration of anterior horn cells (HP:0002398) | 2.68755197 |
| 43 | Aplasia involving forearm bones (HP:0009822) | 2.68252211 |
| 44 | Absent forearm bone (HP:0003953) | 2.68252211 |
| 45 | Type I transferrin isoform profile (HP:0003642) | 2.66366302 |
| 46 | Atrophic scars (HP:0001075) | 2.66089897 |
| 47 | Mitral stenosis (HP:0001718) | 2.65029529 |
| 48 | Cerebral aneurysm (HP:0004944) | 2.62816416 |
| 49 | Premature graying of hair (HP:0002216) | 2.58892222 |
| 50 | Follicular hyperkeratosis (HP:0007502) | 2.57403879 |
| 51 | Abnormality of the ileum (HP:0001549) | 2.56789099 |
| 52 | Wormian bones (HP:0002645) | 2.55694441 |
| 53 | Ankle contracture (HP:0006466) | 2.55323996 |
| 54 | Spondylolisthesis (HP:0003302) | 2.54987620 |
| 55 | Axonal loss (HP:0003447) | 2.54012139 |
| 56 | Dilatation of the ascending aorta (HP:0005111) | 2.51012435 |
| 57 | Loss of speech (HP:0002371) | 2.51006874 |
| 58 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 2.48868438 |
| 59 | Ectopic kidney (HP:0000086) | 2.45199591 |
| 60 | Cardiovascular calcification (HP:0011915) | 2.45120011 |
| 61 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 2.44445204 |
| 62 | Stomach cancer (HP:0012126) | 2.44336739 |
| 63 | Aplastic anemia (HP:0001915) | 2.43041660 |
| 64 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.42956627 |
| 65 | Asymmetric septal hypertrophy (HP:0001670) | 2.42857024 |
| 66 | Stenosis of the external auditory canal (HP:0000402) | 2.42842165 |
| 67 | Increased variability in muscle fiber diameter (HP:0003557) | 2.42350613 |
| 68 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.37937335 |
| 69 | Selective tooth agenesis (HP:0001592) | 2.36658342 |
| 70 | Abnormality of chromosome stability (HP:0003220) | 2.36163512 |
| 71 | Trismus (HP:0000211) | 2.36017179 |
| 72 | External ophthalmoplegia (HP:0000544) | 2.34910092 |
| 73 | Amyloidosis (HP:0011034) | 2.33693569 |
| 74 | Abnormal lung lobation (HP:0002101) | 2.32675118 |
| 75 | Ovoid vertebral bodies (HP:0003300) | 2.30874335 |
| 76 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.30843757 |
| 77 | Myocardial infarction (HP:0001658) | 2.30476424 |
| 78 | Bone marrow hypocellularity (HP:0005528) | 2.30459379 |
| 79 | Abnormal spermatogenesis (HP:0008669) | 2.30010584 |
| 80 | Type 1 muscle fiber predominance (HP:0003803) | 2.27757969 |
| 81 | Fragile skin (HP:0001030) | 2.24271463 |
| 82 | Proximal tubulopathy (HP:0000114) | 2.23056264 |
| 83 | Poor head control (HP:0002421) | 2.22289633 |
| 84 | Abnormality of the preputium (HP:0100587) | 2.22280840 |
| 85 | Distal lower limb muscle weakness (HP:0009053) | 2.20913624 |
| 86 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.20646102 |
| 87 | Secondary amenorrhea (HP:0000869) | 2.20323555 |
| 88 | Neurofibrillary tangles (HP:0002185) | 2.20243472 |
| 89 | Short nail (HP:0001799) | 2.19540069 |
| 90 | Colon cancer (HP:0003003) | 2.19141554 |
| 91 | Abnormal number of erythroid precursors (HP:0012131) | 2.18540515 |
| 92 | Blue sclerae (HP:0000592) | 2.17613678 |
| 93 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.17008833 |
| 94 | Abnormality of the umbilical cord (HP:0010881) | 2.16894439 |
| 95 | Increased connective tissue (HP:0009025) | 2.15001725 |
| 96 | Abnormality of macrophages (HP:0004311) | 2.14877830 |
| 97 | Granulocytopenia (HP:0001913) | 2.14679439 |
| 98 | Ureteral duplication (HP:0000073) | 2.14277087 |
| 99 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.11870799 |
| 100 | Microretrognathia (HP:0000308) | 2.11491529 |
| 101 | Abnormality of the acetabulum (HP:0003170) | 2.11017208 |
| 102 | Irregular epiphyses (HP:0010582) | 2.10883172 |
| 103 | Oral leukoplakia (HP:0002745) | 2.09375643 |
| 104 | Vascular calcification (HP:0004934) | 2.09042219 |
| 105 | Hepatosplenomegaly (HP:0001433) | 2.08214983 |
| 106 | Peritonitis (HP:0002586) | 2.08068880 |
| 107 | Small intestinal stenosis (HP:0012848) | 2.07681349 |
| 108 | Duodenal stenosis (HP:0100867) | 2.07681349 |
| 109 | Progressive neurologic deterioration (HP:0002344) | 2.06812400 |
| 110 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.04431759 |
| 111 | Aneurysm (HP:0002617) | 2.03866598 |
| 112 | Progressive muscle weakness (HP:0003323) | 2.03614284 |
| 113 | Macrocytic anemia (HP:0001972) | 2.03300206 |
| 114 | 11 pairs of ribs (HP:0000878) | 2.03101184 |
| 115 | Soft skin (HP:0000977) | 2.02390037 |
| 116 | Fused cervical vertebrae (HP:0002949) | 2.01995599 |
| 117 | Hematochezia (HP:0002573) | 2.01855043 |
| 118 | 3-Methylglutaconic aciduria (HP:0003535) | 2.00173168 |
| 119 | Abnormality of complement system (HP:0005339) | 1.99144271 |
| 120 | Achilles tendon contracture (HP:0001771) | 1.99079522 |
| 121 | Neoplasm of the pancreas (HP:0002894) | 1.98087285 |
| 122 | Aplasia/Hypoplasia of the earlobes (HP:0009906) | 1.97671437 |
| 123 | Joint stiffness (HP:0001387) | 1.96443131 |
| 124 | Absent thumb (HP:0009777) | 1.96139333 |
| 125 | Horseshoe kidney (HP:0000085) | 1.94905916 |
| 126 | Triphalangeal thumb (HP:0001199) | 1.94166493 |
| 127 | Bladder diverticulum (HP:0000015) | 1.94005999 |
| 128 | Sparse eyelashes (HP:0000653) | 1.93368623 |
| 129 | Supernumerary spleens (HP:0009799) | 1.92971623 |
| 130 | Prolonged neonatal jaundice (HP:0006579) | 1.92638209 |
| 131 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.91478486 |
| 132 | Parakeratosis (HP:0001036) | 1.91332094 |
| 133 | Glomerulonephritis (HP:0000099) | 1.91284508 |
| 134 | Interstitial pulmonary disease (HP:0006530) | 1.90525309 |
| 135 | CNS hypomyelination (HP:0003429) | 1.90451248 |
| 136 | Cleft eyelid (HP:0000625) | 1.89823700 |
| 137 | Upper motor neuron abnormality (HP:0002127) | 1.89482144 |
| 138 | Absent epiphyses (HP:0010577) | 1.88979091 |
| 139 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 1.88979091 |
| 140 | Aplasia/hypoplasia of the humerus (HP:0006507) | 1.88472412 |
| 141 | Hypoplasia of the radius (HP:0002984) | 1.87367608 |
| 142 | Tetraparesis (HP:0002273) | 1.87244436 |
| 143 | Abnormality of the Achilles tendon (HP:0005109) | 1.86904158 |
| 144 | Type 2 muscle fiber atrophy (HP:0003554) | 1.86902005 |
| 145 | Congenital, generalized hypertrichosis (HP:0004540) | 1.86506155 |
| 146 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.84986038 |
| 147 | Abnormality of the fetal cardiovascular system (HP:0010948) | 1.82401973 |
| 148 | Abnormal umbilical cord blood vessels (HP:0011403) | 1.82401973 |
| 149 | Single umbilical artery (HP:0001195) | 1.82401973 |
| 150 | Glossoptosis (HP:0000162) | 1.82348328 |
| 151 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.82037980 |
| 152 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.81856460 |
| 153 | Polycythemia (HP:0001901) | 1.81156378 |
| 154 | Adrenal hypoplasia (HP:0000835) | 1.81127936 |
| 155 | Coxa vara (HP:0002812) | 1.80970074 |
| 156 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.79855417 |
| 157 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.79855417 |
| 158 | Impulsivity (HP:0100710) | 1.78196358 |
| 159 | Skin nodule (HP:0200036) | 1.78159306 |
| 160 | Disinhibition (HP:0000734) | 1.76790245 |
| 161 | Generalized amyotrophy (HP:0003700) | 1.76131298 |
| 162 | Aplasia/Hypoplasia of the breasts (HP:0010311) | 1.75910970 |
| 163 | Short thumb (HP:0009778) | 1.74880079 |
| 164 | Complement deficiency (HP:0004431) | 1.74764963 |
| 165 | Breast aplasia (HP:0100783) | 1.74761375 |
| 166 | Facial cleft (HP:0002006) | 1.74746144 |
| 167 | Agnosia (HP:0010524) | 1.74551421 |
| 168 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.74374509 |
| 169 | Pallor (HP:0000980) | 1.73781580 |
| 170 | Pancytopenia (HP:0001876) | 1.73728807 |
| 171 | Flat capital femoral epiphysis (HP:0003370) | 1.73615106 |
| 172 | Abnormal glycosylation (HP:0012345) | 1.73488693 |
| 173 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.73488693 |
| 174 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.69863502 |
| 175 | Purpura (HP:0000979) | 1.69049571 |
| 176 | Cerebral inclusion bodies (HP:0100314) | 1.67744147 |
| 177 | Mitral regurgitation (HP:0001653) | 1.67449561 |
| 178 | Increased cerebral lipofuscin (HP:0011813) | 1.67368527 |
| 179 | Upper limb amyotrophy (HP:0009129) | 1.66425454 |
| 180 | Distal upper limb amyotrophy (HP:0007149) | 1.66425454 |
| 181 | Hyperextensible skin (HP:0000974) | 1.66109968 |
| 182 | Increased CSF protein (HP:0002922) | 1.65641740 |
| 183 | Elbow flexion contracture (HP:0002987) | 1.63818717 |
| 184 | Slender build (HP:0001533) | 1.63627690 |
| 185 | Acanthosis nigricans (HP:0000956) | 1.61882549 |
| 186 | Striae distensae (HP:0001065) | 1.61158157 |
| 187 | Genu recurvatum (HP:0002816) | 1.60768014 |
| 188 | Abnormality of dentin (HP:0010299) | 1.60627493 |
| 189 | Abnormality of carpal bone ossification (HP:0006257) | 1.60080800 |
| 190 | Aortic valve stenosis (HP:0001650) | 1.58531131 |
| 191 | Conjunctival telangiectasia (HP:0000524) | 1.57243760 |
| 192 | Malnutrition (HP:0004395) | 1.57084807 |
| 193 | Cupped ribs (HP:0000887) | 1.57029246 |
| 194 | Alopecia of scalp (HP:0002293) | 1.56256092 |
| 195 | Hyporeflexia of lower limbs (HP:0002600) | 1.56254328 |
| 196 | Beaking of vertebral bodies (HP:0004568) | 1.53773933 |
| 197 | Petechiae (HP:0000967) | 1.53766475 |
| 198 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.53559286 |
| 199 | Thoracolumbar scoliosis (HP:0002944) | 1.53026274 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PLK4 | 4.51459068 |
| 2 | BUB1 | 4.34817135 |
| 3 | IRAK3 | 4.07745924 |
| 4 | ZAK | 3.36079960 |
| 5 | WEE1 | 3.16719389 |
| 6 | TGFBR2 | 3.07546604 |
| 7 | MYLK | 2.88712063 |
| 8 | STK16 | 2.88513593 |
| 9 | EIF2AK1 | 2.74901909 |
| 10 | SRPK1 | 2.58683576 |
| 11 | ERN1 | 2.46626468 |
| 12 | PDGFRA | 2.46223155 |
| 13 | IRAK4 | 2.25896877 |
| 14 | CDC7 | 2.24330993 |
| 15 | DDR2 | 2.23112412 |
| 16 | MOS | 2.21037907 |
| 17 | BRSK2 | 2.17706427 |
| 18 | EIF2AK3 | 2.12857928 |
| 19 | RIPK1 | 2.12180057 |
| 20 | PTK2 | 2.06381666 |
| 21 | MAP3K12 | 2.00469814 |
| 22 | TTK | 1.99168875 |
| 23 | LATS2 | 1.97756030 |
| 24 | PBK | 1.92428829 |
| 25 | NEK9 | 1.84995708 |
| 26 | TESK2 | 1.81974254 |
| 27 | PINK1 | 1.79964830 |
| 28 | MST1R | 1.79160316 |
| 29 | EPHA2 | 1.78333128 |
| 30 | VRK1 | 1.75429162 |
| 31 | MKNK1 | 1.75313986 |
| 32 | TTN | 1.71001483 |
| 33 | EPHB2 | 1.66510018 |
| 34 | TSSK6 | 1.65221994 |
| 35 | MAP2K3 | 1.62245026 |
| 36 | NME2 | 1.61467202 |
| 37 | MAP3K2 | 1.60083951 |
| 38 | TYK2 | 1.56589757 |
| 39 | EPHB1 | 1.56412381 |
| 40 | IRAK2 | 1.54630523 |
| 41 | PLK3 | 1.53626313 |
| 42 | PRPF4B | 1.51958569 |
| 43 | IRAK1 | 1.49677843 |
| 44 | PLK1 | 1.47620226 |
| 45 | PASK | 1.47154706 |
| 46 | ACVR1B | 1.45471733 |
| 47 | ARAF | 1.34592561 |
| 48 | KDR | 1.31721250 |
| 49 | LIMK1 | 1.28947449 |
| 50 | KSR2 | 1.21530935 |
| 51 | ATR | 1.21034636 |
| 52 | STK38 | 1.20673191 |
| 53 | TESK1 | 1.20041974 |
| 54 | BMPR2 | 1.18568750 |
| 55 | PAK2 | 1.18374981 |
| 56 | FER | 1.15963912 |
| 57 | STK38L | 1.12223620 |
| 58 | ZAP70 | 1.10862635 |
| 59 | MAP3K1 | 1.10281612 |
| 60 | DYRK3 | 1.10097245 |
| 61 | AURKB | 1.09691495 |
| 62 | GRK7 | 1.07641981 |
| 63 | CHEK2 | 1.06267399 |
| 64 | TRIB3 | 1.06178730 |
| 65 | NEK2 | 1.03325901 |
| 66 | CDK7 | 1.02693246 |
| 67 | RPS6KA4 | 1.01734529 |
| 68 | PDGFRB | 0.99312699 |
| 69 | PAK4 | 0.97924358 |
| 70 | ILK | 0.96111540 |
| 71 | MAPKAPK3 | 0.95590041 |
| 72 | EIF2AK2 | 0.93963329 |
| 73 | PIM2 | 0.93038226 |
| 74 | BRSK1 | 0.92980432 |
| 75 | PRKG2 | 0.92710270 |
| 76 | CLK1 | 0.90609871 |
| 77 | NEK6 | 0.90584246 |
| 78 | DMPK | 0.90420538 |
| 79 | MKNK2 | 0.90254619 |
| 80 | STK4 | 0.90039848 |
| 81 | CDC42BPA | 0.87969761 |
| 82 | SCYL2 | 0.87886070 |
| 83 | MAP3K8 | 0.86907063 |
| 84 | JAK1 | 0.86783440 |
| 85 | RPS6KA5 | 0.85904779 |
| 86 | BCR | 0.84399106 |
| 87 | MAP3K6 | 0.84203726 |
| 88 | CSK | 0.83535624 |
| 89 | NTRK1 | 0.82827423 |
| 90 | FGFR3 | 0.82197222 |
| 91 | TBK1 | 0.81747128 |
| 92 | ROCK2 | 0.80556534 |
| 93 | MST4 | 0.79830243 |
| 94 | RPS6KB2 | 0.79404744 |
| 95 | STK10 | 0.78016820 |
| 96 | TIE1 | 0.77299491 |
| 97 | AURKA | 0.76122483 |
| 98 | MAP3K13 | 0.74672629 |
| 99 | STK39 | 0.73860795 |
| 100 | MAP3K14 | 0.72552240 |
| 101 | SIK1 | 0.72399569 |
| 102 | CHEK1 | 0.71737714 |
| 103 | MET | 0.71017046 |
| 104 | PRKD2 | 0.70656678 |
| 105 | PTK2B | 0.69976769 |
| 106 | MAPKAPK5 | 0.68925577 |
| 107 | ERBB4 | 0.68864912 |
| 108 | DYRK2 | 0.67777957 |
| 109 | TLK1 | 0.67686895 |
| 110 | TGFBR1 | 0.66559995 |
| 111 | CDK6 | 0.64067928 |
| 112 | BMPR1B | 0.63825311 |
| 113 | JAK3 | 0.63669359 |
| 114 | BMX | 0.63375944 |
| 115 | PDPK1 | 0.62436231 |
| 116 | STK3 | 0.61834115 |
| 117 | GSK3A | 0.59232951 |
| 118 | PAK1 | 0.58360078 |
| 119 | PIK3CG | 0.57673693 |
| 120 | CSNK2A1 | 0.56812362 |
| 121 | BRAF | 0.55529532 |
| 122 | FGR | 0.55492364 |
| 123 | ATM | 0.54588430 |
| 124 | PRKCI | 0.54585277 |
| 125 | PTK6 | 0.54539507 |
| 126 | ABL2 | 0.54015983 |
| 127 | MAP3K5 | 0.53917770 |
| 128 | NUAK1 | 0.53745162 |
| 129 | STK24 | 0.52577136 |
| 130 | NLK | 0.51923651 |
| 131 | ROCK1 | 0.50682011 |
| 132 | WNK1 | 0.50291904 |
| 133 | BRD4 | 0.49936885 |
| 134 | AKT3 | 0.49822093 |
| 135 | KSR1 | 0.48841155 |
| 136 | ERBB3 | 0.47514304 |
| 137 | LMTK2 | 0.47439845 |
| 138 | MAP3K3 | 0.46082610 |
| 139 | YES1 | 0.45836812 |
| 140 | MARK1 | 0.45719428 |
| 141 | NME1 | 0.44740911 |
| 142 | MAP2K1 | 0.44333000 |
| 143 | FGFR4 | 0.44111809 |
| 144 | CDK8 | 0.44001038 |
| 145 | DAPK3 | 0.43864553 |
| 146 | SIK3 | 0.43458041 |
| 147 | CDK9 | 0.41964701 |
| 148 | MAP2K2 | 0.41734357 |
| 149 | CDK2 | 0.41164285 |
| 150 | IKBKB | 0.40763603 |
| 151 | PIM1 | 0.40408766 |
| 152 | TEC | 0.40156329 |
| 153 | CSNK2A2 | 0.40152658 |
| 154 | FLT3 | 0.38121956 |
| 155 | RAF1 | 0.37830935 |
| 156 | MELK | 0.37704698 |
| 157 | PDK2 | 0.37340271 |
| 158 | CAMK2D | 0.36689379 |
| 159 | NEK1 | 0.35614940 |
| 160 | CDK1 | 0.34509060 |
| 161 | LRRK2 | 0.34414956 |
| 162 | MAP3K11 | 0.32920831 |
| 163 | MARK3 | 0.32721070 |
| 164 | BCKDK | 0.30894302 |
| 165 | MAPKAPK2 | 0.28654598 |
| 166 | CSNK1G3 | 0.27278614 |
| 167 | CDK3 | 0.26710943 |
| 168 | TRPM7 | 0.25072547 |
| 169 | TAOK2 | 0.23982851 |
| 170 | CSNK1A1L | 0.23841049 |
| 171 | LATS1 | 0.22787588 |
| 172 | CHUK | 0.22587765 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 4.11730633 |
| 2 | RNA polymerase_Homo sapiens_hsa03020 | 4.00930094 |
| 3 | Proteasome_Homo sapiens_hsa03050 | 3.70290973 |
| 4 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.64207024 |
| 5 | Mismatch repair_Homo sapiens_hsa03430 | 3.33761241 |
| 6 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 3.23684559 |
| 7 | Ribosome_Homo sapiens_hsa03010 | 3.06099105 |
| 8 | Spliceosome_Homo sapiens_hsa03040 | 2.79771929 |
| 9 | Homologous recombination_Homo sapiens_hsa03440 | 2.72332164 |
| 10 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.70835569 |
| 11 | Base excision repair_Homo sapiens_hsa03410 | 2.46397100 |
| 12 | RNA transport_Homo sapiens_hsa03013 | 2.42845292 |
| 13 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.37196531 |
| 14 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.32987962 |
| 15 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 2.23502174 |
| 16 | Protein export_Homo sapiens_hsa03060 | 2.21015613 |
| 17 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.18796619 |
| 18 | Cell cycle_Homo sapiens_hsa04110 | 2.18601882 |
| 19 | Basal transcription factors_Homo sapiens_hsa03022 | 2.17408574 |
| 20 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.79610966 |
| 21 | Focal adhesion_Homo sapiens_hsa04510 | 1.78138021 |
| 22 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.77660677 |
| 23 | Amoebiasis_Homo sapiens_hsa05146 | 1.74088808 |
| 24 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.72170947 |
| 25 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.68007321 |
| 26 | RNA degradation_Homo sapiens_hsa03018 | 1.65793030 |
| 27 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.64361409 |
| 28 | Purine metabolism_Homo sapiens_hsa00230 | 1.60585146 |
| 29 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.60278910 |
| 30 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.55056476 |
| 31 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.54486971 |
| 32 | Galactose metabolism_Homo sapiens_hsa00052 | 1.50894628 |
| 33 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.45172572 |
| 34 | Bladder cancer_Homo sapiens_hsa05219 | 1.42044027 |
| 35 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.40737216 |
| 36 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.38880364 |
| 37 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.38065039 |
| 38 | * Phagosome_Homo sapiens_hsa04145 | 1.31361290 |
| 39 | Salmonella infection_Homo sapiens_hsa05132 | 1.26985337 |
| 40 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.22035088 |
| 41 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.21347003 |
| 42 | Prion diseases_Homo sapiens_hsa05020 | 1.21249895 |
| 43 | Adherens junction_Homo sapiens_hsa04520 | 1.19505159 |
| 44 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.13302207 |
| 45 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.12672850 |
| 46 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.12272731 |
| 47 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.10733650 |
| 48 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.09718317 |
| 49 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.07962656 |
| 50 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.99007779 |
| 51 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.98765936 |
| 52 | Endocytosis_Homo sapiens_hsa04144 | 0.96097039 |
| 53 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.96069839 |
| 54 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.95220124 |
| 55 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.94736081 |
| 56 | Mineral absorption_Homo sapiens_hsa04978 | 0.93658487 |
| 57 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.93016621 |
| 58 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.92663191 |
| 59 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.91132436 |
| 60 | Huntingtons disease_Homo sapiens_hsa05016 | 0.90778944 |
| 61 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.90069981 |
| 62 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.90026550 |
| 63 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.89990967 |
| 64 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.89606523 |
| 65 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.86183992 |
| 66 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.85856655 |
| 67 | Parkinsons disease_Homo sapiens_hsa05012 | 0.85452667 |
| 68 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.84284483 |
| 69 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.83915043 |
| 70 | Tuberculosis_Homo sapiens_hsa05152 | 0.83445077 |
| 71 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.81469184 |
| 72 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.80185829 |
| 73 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.79220031 |
| 74 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.78561241 |
| 75 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.77851979 |
| 76 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.75088948 |
| 77 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.73609087 |
| 78 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.69937690 |
| 79 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.69680499 |
| 80 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.69090715 |
| 81 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.68997446 |
| 82 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.68569695 |
| 83 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.68157949 |
| 84 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.66843338 |
| 85 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.66740467 |
| 86 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.66401975 |
| 87 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.65306625 |
| 88 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.64557717 |
| 89 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.64324703 |
| 90 | Legionellosis_Homo sapiens_hsa05134 | 0.63251360 |
| 91 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.62557282 |
| 92 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.62549382 |
| 93 | Circadian rhythm_Homo sapiens_hsa04710 | 0.62118835 |
| 94 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.62084556 |
| 95 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.60667528 |
| 96 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.59259209 |
| 97 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.59023354 |
| 98 | Other glycan degradation_Homo sapiens_hsa00511 | 0.58742347 |
| 99 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.58520444 |
| 100 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.58437934 |
| 101 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.58430121 |
| 102 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.58169301 |
| 103 | Platelet activation_Homo sapiens_hsa04611 | 0.57363545 |
| 104 | Hepatitis C_Homo sapiens_hsa05160 | 0.56920157 |
| 105 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.55762969 |
| 106 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.55309076 |
| 107 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.54895911 |
| 108 | Insulin resistance_Homo sapiens_hsa04931 | 0.54878850 |
| 109 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.54297791 |
| 110 | HTLV-I infection_Homo sapiens_hsa05166 | 0.53299848 |
| 111 | Shigellosis_Homo sapiens_hsa05131 | 0.51432316 |
| 112 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.50306243 |
| 113 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.50109035 |
| 114 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.49669162 |
| 115 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.48425016 |
| 116 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.48227363 |
| 117 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.47843793 |
| 118 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.47114079 |
| 119 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.46634750 |
| 120 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.46595697 |
| 121 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.45745634 |
| 122 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.45179503 |
| 123 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.44943179 |
| 124 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.44892899 |
| 125 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.44017106 |
| 126 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.42397519 |
| 127 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.41809696 |
| 128 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.41721163 |
| 129 | Carbon metabolism_Homo sapiens_hsa01200 | 0.41573145 |
| 130 | Lysosome_Homo sapiens_hsa04142 | 0.41408786 |
| 131 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.41400172 |
| 132 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.41031792 |
| 133 | Histidine metabolism_Homo sapiens_hsa00340 | 0.41012583 |
| 134 | Malaria_Homo sapiens_hsa05144 | 0.40989612 |
| 135 | Metabolic pathways_Homo sapiens_hsa01100 | 0.40484510 |
| 136 | Glioma_Homo sapiens_hsa05214 | 0.40442600 |
| 137 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.39888221 |
| 138 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.39034708 |
| 139 | Measles_Homo sapiens_hsa05162 | 0.37876318 |
| 140 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.37683056 |
| 141 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.37427068 |
| 142 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.37103029 |
| 143 | Apoptosis_Homo sapiens_hsa04210 | 0.36094226 |
| 144 | Asthma_Homo sapiens_hsa05310 | 0.35790695 |
| 145 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.35417889 |
| 146 | Leishmaniasis_Homo sapiens_hsa05140 | 0.35268094 |
| 147 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.34580814 |
| 148 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.34515344 |
| 149 | * SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.34131825 |
| 150 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.34043090 |
| 151 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.33080393 |
| 152 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.32450372 |
| 153 | Allograft rejection_Homo sapiens_hsa05330 | 0.32381494 |
| 154 | Pertussis_Homo sapiens_hsa05133 | 0.30780115 |
| 155 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.30003529 |
| 156 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.29549000 |
| 157 | Alzheimers disease_Homo sapiens_hsa05010 | 0.29394354 |
| 158 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.29320540 |
| 159 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.28339643 |
| 160 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.27819334 |
| 161 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.27081895 |
| 162 | Tight junction_Homo sapiens_hsa04530 | 0.26817320 |
| 163 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.26084299 |
| 164 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.25993909 |
| 165 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.25863167 |
| 166 | Thyroid cancer_Homo sapiens_hsa05216 | 0.25634183 |
| 167 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.25183071 |
| 168 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.25148534 |
| 169 | Influenza A_Homo sapiens_hsa05164 | 0.24361639 |
| 170 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.24203682 |
| 171 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.23945678 |

